MG
IONS icon

Marex Group’s Ionis Pharmaceuticals IONS Stock Holding History

Marex Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$271K Buy
3,610
+86
+2% +$6.79K ﹤0.01% 807
2025
Q4 		$279K Sell
3,524
-3,198
-48% -$241K ﹤0.01% 724
2025
Q3 		$440K Sell
6,722
-76,639
-92% -$3.74M ﹤0.01% 522
2025
Q2 		$3.29M Buy
+83,361
New +$2.73M 0.03% 190

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marex Group's IONS Position: Q1 2026 in Review

Marex Group increased its Ionis Pharmaceuticals (IONS) stake by 2.4% in Q1 2026, buying an estimated $6.79K and bringing the position to 3,610 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #807.

Marex Group first reported a position in IONS in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.29M in Q2 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Marex Group held 3,610 shares of Ionis Pharmaceuticals worth $271K as of Q1 2026.
  • Marex Group bought 86 Ionis Pharmaceuticals shares in Q1 2026, an estimated $6.79K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #807 holding.
  • Marex Group first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Marex Group's Ionis Pharmaceuticals position peaked at $3.29M in Q2 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.